Oxford considers the variant top priority for vaccine developers, and AstraZeneca has targeted the development of new vaccines against variants by the autumn.
U.K. seeks modified AstraZeneca shots to tackle Beta COVID-19 variant
Oxford considers the variant top priority for vaccine developers, and AstraZeneca has targeted the development of new vaccines against variants by the autumn.